年龄相关性黄斑变性中网状假性玻璃膜疣的患病率、风险及遗传关联:年龄相关性眼病研究2报告21
本研究基于AREDS2前瞻性队列中5021只眼(2516名参与者)的眼底自发荧光图像,评估网状假性玻璃膜疣(RPD)在年龄相关性黄斑变性(AMD)中的患病率及其作为晚期AMD独立危险因素的作用。结果显示RPD见于24%的眼和29%的参与者,其存在与进展为地图样萎缩的风险增加相关(OR 2.42,95%CI 1.80-3.24),但与新生血管性AMD无显著关联(OR 1.21,95%CI 0.87-1.7)。RPD与ARMS2风险等位基因及较高遗传风险评分显著相关。
要点
- RPD见于24%的AMD眼和29%的参与者,患病率随基线AMD严重程度从早期6%至地图样萎缩36%变化。
- 调整混杂因素后,RPD与进展为地图样萎缩的风险增加相关(OR 2.42,95%CI 1.80-3.24),与新生血管性AMD无显著关联(OR 1.21,95%CI 0.87-1.7)。
- RPD与ARMS2风险等位基因及较高遗传风险评分显著相关。
核心结论
- 伴有RPD的参与者进展为地图样萎缩的风险增加,但进展为新生血管性AMD的风险未增加。
- ARMS2风险等位基因和较高遗传风险评分与RPD的存在相关。
- 本研究提示RPD是重要的风险标志物,应纳入用于患者预后判断的分类系统。
研究设计与样本
- 前瞻性队列研究,纳入年龄相关性眼病研究2(AREDS2)中单眼或双眼中期AMD的参与者,AREDS2为为期5年的多中心营养补充剂研究。
- 对AREDS2部分参与者的眼底自发荧光图像在每年随访时评估RPD存在情况。
- 评估6个单核苷酸多态性(rs10490924、rs1061170、rs2230199、rs116503776、rs114254831、rs943080)及遗传风险评分与RPD的关联。
主要发现
- 共评估5021只眼(2516名参与者)的眼底自发荧光图像,RPD见于1186只眼(占24%的眼,占29%的参与者)。
- RPD患病率随基线AREDS AMD严重程度变化:早期AMD为6%(n=458),中期AMD为26%(n=2606),地图样萎缩为36%(n=682),新生血管性AMD为19%(n=1246)。
- 有RPD的参与者平均年龄为79岁(标准差7),无RPD者为75岁(标准差8)(P < 0.0001)。
- RPD在女性参与者中更常见(有RPD者65% vs 无RPD者53%)。
- 对1710只在下一次年度随访时有晚期AMD风险的眼的分析中,调整基线年龄、性别、种族、教育状况、吸烟和AMD严重程度后,进展为地图样萎缩的OR为2.42(95%CI 1.80-3.24;P < 0.001),进展为新生血管性AMD的OR为1.21(95%CI 0.87-1.7;P = 0.26)。
关键数值与推荐
- RPD的存在与较高遗传风险评分显著相关(P < 0.0001),与ARMS2风险等位基因显著相关(P < 0.0001)。
- RPD在名义水平上与C3风险等位基因相关(P = 0.04),与CFH风险等位基因相关(纯合子P = 0.048)。
临床怎么用
- 本研究提示RPD是重要的风险标志物,应纳入用于患者预后判断的分类系统。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the prevalence of reticular pseudodrusen (RPD) in eyes with age-related macular degeneration (AMD), assess the role of RPD as an independent risk factor for late AMD development, and evaluate genetic association with RPD. DESIGN: Prospective cohort study. PARTICIPANTS: Participants with intermediate AMD in 1 or both eyes enrolled in the Age-Related Eye Disease Study 2 (AREDS2), a 5-year multicenter study of nutritional supplement. METHODS: Fundus autofluorescence (FAF) images from a subset of AREDS2 participants were evaluated at annual visits for presence of RPD. Six single nucleotide polymorphisms-rs10490924 (ARMS2), rs1061170 (CFH), rs2230199 (C3), rs116503776 and rs114254831 (C2/CFB), and rs943080 (VEGF-A)-and the genetic risk score (GRS) were assessed for association with RPD. Development of late AMD, defined as geographic atrophy (GA) or neovascular AMD (NVAMD), was identified. MAIN OUTCOME MEASURES: Prevalence of RPD, odds ratio (OR) of late AMD development, and genetic associations of RPD. RESULTS: The FAF images were evaluated for 5021 eyes (2516 participants). Reticular pseudodrusen were seen in 1186 eyes (24% of eyes, 29% of participants). Prevalence of RPD varied with baseline AREDS AMD severity level: 6% in early AMD (n = 458), 26% in intermediate AMD (n = 2606), 36% in GA (n = 682), and 19% in NVAMD (n = 1246). Mean age of participants with RPD was 79 years (standard deviation [SD], 7) and 75 years (SD, 8) in those without RPD (P < 0.0001). Reticular pseudodrusen were more frequent in female participants (65% RPD vs. 53% no RPD). Odds ratio adjusted for baseline age, gender, race, educational status, smoking, and AMD severity level for 1710 eyes at risk of developing late AMD at the next annual visit was 2.42 (95% confidence interval [CI], 1.80-3.24; P < 0.001) for GA and 1.21 (95% CI, 0.87-1.7; P = 0.26) for NVAMD. Presence of RPD was significantly associated with higher GRS (P < 0.0001) and ARMS2 risk alleles (P < 0.0001) and, at a nominal level, with C3 risk alleles (P = 0.04) and CFH risk alleles (P = 0.048 for homozygotes). CONCLUSIONS: Participants with RPD have an increased risk of progression to GA but not NVAMD. ARMS2 risk alleles and higher GRS were associated with the presence of RPD. This study suggests that RPD are an important risk marker and should be included in classification systems used for patient prognosis.
引用
- Domalpally A, Agrón E, Pak JW, et al. Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21. Ophthalmology. 2019. PMID: 31558345. doi:10.1016/j.ophtha.2019.07.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。